$AXGN
Axogen, Inc.

2020 Q1 Form 10-K Financial Statement

#000155837020001238 Filed on February 24, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2018 Q4 2018 Q3
Revenue $24.26M $23.43M $22.66M
YoY Change 4.19% 38.08% 41.18%
Cost Of Revenue $4.816M $4.100M $3.464M
YoY Change 29.67% 38.98% 22.84%
Gross Profit $19.45M $19.79M $19.20M
YoY Change -0.64% 41.18% 45.2%
Gross Profit Margin 80.15% 84.47% 84.71%
Selling, General & Admin $23.34M $21.38M $20.72M
YoY Change -8.95% 54.37% 60.28%
% of Gross Profit 120.03% 108.02% 107.96%
Research & Development $4.614M $3.810M $3.307M
YoY Change 11.48% 93.4% 83.72%
% of Gross Profit 23.73% 19.25% 17.23%
Depreciation & Amortization $307.0K $220.0K $200.0K
YoY Change 45.5% 37.5% 33.33%
% of Gross Profit 1.58% 1.11% 1.04%
Operating Expenses $27.95M $25.19M $24.03M
YoY Change -6.11% 59.13% 63.25%
Operating Profit -$8.509M -$5.397M -$4.835M
YoY Change -16.6% 198.18% 222.33%
Interest Expense $31.00K $640.0K $730.0K
YoY Change -95.57% -192.75% -217.74%
% of Operating Profit
Other Income/Expense, Net $317.0K -$10.00K $733.0K
YoY Change -54.65% 0.0%
Pretax Income -$8.190M -$5.230M -$4.100M
YoY Change -13.79% 109.2% 93.4%
Income Tax
% Of Pretax Income
Net Earnings -$8.192M -$5.224M -$4.102M
YoY Change -13.8% 108.96% 93.49%
Net Earnings / Revenue -33.77% -22.29% -18.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$206.3K -$134.9K -$106.5K
COMMON SHARES
Basic Shares Outstanding 39.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.00M $116.6M $126.4M
YoY Change -23.01% 219.45% 474.55%
Cash & Equivalents $35.89M $24.29M $25.63M
Short-Term Investments $47.10M $92.30M $100.7M
Other Short-Term Assets $9.700M $7.000M $1.500M
YoY Change 2.11% 677.78% 150.0%
Inventory $14.56M $11.98M $10.90M
Prepaid Expenses
Receivables $13.02M $15.32M $14.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $120.4M $151.0M $152.8M
YoY Change -17.34% 171.01% 286.84%
LONG-TERM ASSETS
Property, Plant & Equipment $20.06M $8.039M $7.700M
YoY Change 46.45% 265.41% 327.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.53M $9.220M $8.900M
YoY Change 64.64% 188.13% 229.63%
TOTAL ASSETS
Total Short-Term Assets $120.4M $151.0M $152.8M
Total Long-Term Assets $24.53M $9.220M $8.900M
Total Assets $144.9M $160.2M $161.7M
YoY Change -9.73% 171.94% 283.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.184M $4.517M $4.800M
YoY Change -2.92% 41.16% 128.57%
Accrued Expenses $12.30M $8.500M $7.200M
YoY Change 36.67% 49.12% 44.0%
Deferred Revenue $14.00K $18.00K $23.00K
YoY Change -41.67% -43.75%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $1.785M $28.00K $0.00
YoY Change -96.0%
Total Short-Term Liabilities $19.49M $13.04M $12.00M
YoY Change 18.11% -4.79% 8.11%
LONG-TERM LIABILITIES
Long-Term Debt $1.189M $35.00K $0.00
YoY Change -99.82% -100.0%
Other Long-Term Liabilities $1.200M $70.00K $100.0K
YoY Change -62.5% -65.0% -50.0%
Total Long-Term Liabilities $1.189M $105.0K $100.0K
YoY Change -62.84% -99.48% -99.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.49M $13.04M $12.00M
Total Long-Term Liabilities $1.189M $105.0K $100.0K
Total Liabilities $20.69M $13.19M $12.20M
YoY Change 5.02% -60.86% -61.51%
SHAREHOLDERS EQUITY
Retained Earnings -$188.1M -$150.7M
YoY Change
Common Stock $312.2M $297.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $124.2M $147.0M $149.5M
YoY Change
Total Liabilities & Shareholders Equity $144.9M $160.2M $161.7M
YoY Change -9.73% 171.94% 283.18%

Cashflow Statement

Concept 2020 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$8.192M -$5.224M -$4.102M
YoY Change -13.8% 108.96% 93.49%
Depreciation, Depletion And Amortization $307.0K $220.0K $200.0K
YoY Change 45.5% 37.5% 33.33%
Cash From Operating Activities -$8.052M -$4.970M -$2.970M
YoY Change -9.19% 373.33% 37.5%
INVESTING ACTIVITIES
Capital Expenditures $5.021M -$230.0K -$5.460M
YoY Change 950.42% -53.06% 1850.0%
Acquisitions
YoY Change
Other Investing Activities $13.69M $8.780M -$100.4M
YoY Change 65.74%
Cash From Investing Activities $8.550M $8.550M -$105.8M
YoY Change 10.04% -1844.9% 37696.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $639.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$328.0K 1.090M 860.0K
YoY Change -200.92% -93.19% 38.71%
NET CHANGE
Cash From Operating Activities -$8.052M -4.970M -2.970M
Cash From Investing Activities $8.550M 8.550M -105.8M
Cash From Financing Activities -$328.0K 1.090M 860.0K
Net Change In Cash $170.0K 4.670M -107.9M
YoY Change -122.02% -67.7% 5830.77%
FREE CASH FLOW
Cash From Operating Activities -$8.052M -$4.970M -$2.970M
Capital Expenditures $5.021M -$230.0K -$5.460M
Free Cash Flow -$13.07M -$4.740M $2.490M
YoY Change 39.89% 746.43% -232.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32615
CY2019 dei City Area Code
CityAreaCode
386
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38900875
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39589755
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000805928
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtCurrent us-gaap:LongTermDebtNoncurrent
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-36046
CY2019 dei Entity Registrant Name
EntityRegistrantName
AXOGEN, INC.
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1301878
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
13631 Progress Blvd., Suite 400
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Alachua
CY2019 dei Local Phone Number
LocalPhoneNumber
462-6800
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
539757783
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39731078
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35724000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24294000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
6000000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
6000000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
60786000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16944000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15321000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
92311000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1092000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1117000
CY2019Q4 us-gaap Inventory Net
InventoryNet
13861000
CY2018Q4 us-gaap Inventory Net
InventoryNet
11982000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1706000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1045000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
135021000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
150953000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14887000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8039000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3133000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
87000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1515000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1181000
CY2019Q4 us-gaap Assets
Assets
154643000
CY2018Q4 us-gaap Assets
Assets
160173000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19130000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12998000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1736000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20880000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13044000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1595000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
35000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
42000
CY2019Q4 us-gaap Liabilities
Liabilities
22490000
CY2018Q4 us-gaap Liabilities
Liabilities
13191000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39589755
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38900875
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
396000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
389000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
311618000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
297319000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179861000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150726000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
132153000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
146982000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154643000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160173000
CY2019 us-gaap Revenues
Revenues
106712000
CY2018 us-gaap Revenues
Revenues
83937000
CY2017 us-gaap Revenues
Revenues
60426000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17349000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12923000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9311000
CY2019 us-gaap Gross Profit
GrossProfit
89363000
CY2018 us-gaap Gross Profit
GrossProfit
71014000
CY2017 us-gaap Gross Profit
GrossProfit
51115000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1434000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15663000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
14921000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3609000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
71950000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
56617000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37636000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17514000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11773000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6699000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31305000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23124000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14731000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
120769000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
91514000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
59066000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-31406000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-20500000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-7951000
CY2019 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2364000
CY2018 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1525000
CY2019 us-gaap Interest Expense
InterestExpense
40000
CY2018 us-gaap Interest Expense
InterestExpense
1127000
CY2017 us-gaap Interest Expense
InterestExpense
2217000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
81000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
246000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2186000
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
53000
CY2018 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
28000
CY2017 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
31000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2271000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1897000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2494000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-29135000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-22397000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-10445000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39235
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37127
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33323
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-10445000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
25182000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7606000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3884000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
132707000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-22397000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0628
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
192000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
342000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2920000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
146982000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10304000
CY2019 axgn Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
4002000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-29135000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
132153000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-29135000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-22397000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-10445000
CY2019 us-gaap Depreciation
Depreciation
933000
CY2018 us-gaap Depreciation
Depreciation
774000
CY2017 us-gaap Depreciation
Depreciation
488000
CY2019 axgn Right Of Use Asset Amortization
RightOfUseAssetAmortization
1821000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
123000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
104000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
81000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
246000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2186000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
514000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
852000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
223000
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
1887000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
1343000
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
1438000
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
972000
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
721000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
10304000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7606000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3609000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2136000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5108000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3236000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3767000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6009000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3295000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
661000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3711000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1927000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1773000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
4000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-30000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-66000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
70000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19872000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17862000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9238000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4664000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6282000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1105000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
121074000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
114736000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
153571000
CY2018 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
23146000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
562000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
321000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
187000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27271000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98193000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1292000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
132964000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15891000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
257000
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
228000
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
26253000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
57599000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
30489000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
57624000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22513000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
29000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4002000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3884000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1434000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4031000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
109842000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17022000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11430000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6213000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6492000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30294000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36507000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30015000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41724000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30294000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36507000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
34000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1325000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
2198000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3212000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
335000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
55000
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
62000
CY2019 axgn Noncash Right Of Use Assets And Operating Lease Liability
NoncashRightOfUseAssetsAndOperatingLeaseLiability
26000
CY2019 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">1.</b></span><b style="font-weight:bold;">Basis of Presentation </b></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:14.4pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">The accompanying consolidated financial statements include the accounts of Axogen, Inc. (the “Company” or “Axogen”) and its wholly owned subsidiaries, Axogen Corporation (“AC”), Axogen Processing Corporation (“APC”) and Axogen Europe GmbH, as of December 31, 2019 and December 31, 2018 and for the three years ended December 31, 2019. The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. All intercompany accounts and transactions have been eliminated in consolidation.</p>
CY2019 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">2.</b></span><b style="font-weight:bold;">Organization and Business </b></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:14.4pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Axogen is a global provider of innovative surgical solutions for physical damage or transection to peripheral nerves. Axogen is focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Axogen’s products are designed to restore nerve function and are used to treat patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Physical damage to a peripheral nerve or the inability to properly reconnect peripheral nerves can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. </span></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">Axogen’s portfolio of products includes Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site, Axoguard Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed peripheral nerves, Axoguard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments, Axoguard<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">®</sup> Nerve Cap, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissues in the surgical bed.<span style="white-space:pre-wrap;"> Along with these core surgical products, Axogen also offers the Axotouch Two-Point Discriminator a measurement tool for use by healthcare professionals detect changes in sensation. The Company’s portfolio of products is available in the United States, Canada, Germany, South Korea and other European and international countries.</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Avance Nerve Graft and Avive Soft Tissue Membrane are processed in the United States by Axogen at its processing facility in Dayton, Ohio. </span>Axoguard Nerve Cap<span style="white-space:pre-wrap;"> is manufactured by Cook Biotech in the United States for sale by Axogen and Axoguard Nerve Connector and Axoguard Nerve Protector are manufactured in the United States by Cook Biotech and are distributed worldwide exclusively by Axogen. The Axotouch Two Point Discriminator is contract manufactured by Viron Technologies, LLC (formerly Cybernetics Research Laboratories) (“Viron”) Tucson, Arizona. Viron supplies the Axotouch unpackaged and they are packaged at Axogen’s distribution facility in Burleson, Texas. Axogen maintains its corporate offices in Alachua, Florida and is the parent company of its wholly owned operating subsidiaries, AC, APC and Axogen Europe GmbH.</span></p>
CY2018Q3 us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
731000
CY2018Q3 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
4300000
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
35224000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
6000000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35724000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24294000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
6000000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
6000000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41724000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30294000
CY2017Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
11065000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
69000
CY2018Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
15321000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
42000
CY2018 axgn Increase Decrease In Contract Receivable
IncreaseDecreaseInContractReceivable
4256000
CY2018 axgn Increase Decrease In Contract With Customer Liability Current
IncreaseDecreaseInContractWithCustomerLiabilityCurrent
-14000
CY2018 axgn Increase Decrease In Contract With Customer Liability Noncurrent
IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent
-27000
CY2019Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
16944000
CY2018Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
15321000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
42000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15000
CY2019 axgn Increase Decrease In Contract Receivable
IncreaseDecreaseInContractReceivable
1623000
CY2019 axgn Increase Decrease In Contract With Customer Liability Current
IncreaseDecreaseInContractWithCustomerLiabilityCurrent
-4000
CY2019 axgn Increase Decrease In Contract With Customer Liability Noncurrent
IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent
-27000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1092000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1117000
CY2019Q4 axgn Finance And Operating Lease Right Of Use Asset
FinanceAndOperatingLeaseRightOfUseAsset
3786000
CY2019Q4 axgn Finance And Operating Lease Liabilities
FinanceAndOperatingLeaseLiabilities
3823000
CY2019Q1 axgn Derecognition Of Capital Lease Assets
DerecognitionOfCapitalLeaseAssets
96000
CY2019Q1 axgn Derecognition Of Capital Lease Liabilities
DerecognitionOfCapitalLeaseLiabilities
63000
CY2019Q1 axgn Derecognition Of Deferred Rent
DerecognitionOfDeferredRent
70000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1556818
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2621440
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2253399
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17514000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11773000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6699000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6699000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
10304000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7606000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3609000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Use of Estimates</b></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes the critical accounting policies regarding revenue recognition, allowance for uncollectible accounts receivable, investments, inventories and share-based employee compensation affect our more significant judgments and estimates used in the </span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">preparation of the Company’s consolidated financial statements. Actual results could differ materially from those estimates.</span></p>
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10403000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9194000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
730000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
454000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2728000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2334000
CY2019Q4 us-gaap Inventory Net
InventoryNet
13861000
CY2018Q4 us-gaap Inventory Net
InventoryNet
11982000
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
1887000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
1343000
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
1438000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18651000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10900000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3764000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2861000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14887000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8039000
CY2019 us-gaap Depreciation
Depreciation
933000
CY2018 us-gaap Depreciation
Depreciation
774000
CY2017 us-gaap Depreciation
Depreciation
488000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1515000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1181000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
123000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
285000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8262000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4517000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3237000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2004000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
7631000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6477000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19130000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12998000
CY2018Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
63000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
28000
CY2018Q4 axgn Long Term Debt Noncurrent Excluding Deferred Revenue
LongTermDebtNoncurrentExcludingDeferredRevenue
35000
CY2018Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22599000
CY2018Q2 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1470000
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
473000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10304000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7606000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3609000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
23000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4002000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3884000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1434000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1467000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
196000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
108000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M3D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M19D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M28D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5497
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5099
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5043
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0171
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0270
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0212
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36250000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30588000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27578000
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
317000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
273000
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
206000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
136000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
117000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q4 axgn Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
336000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
274000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
117000
CY2019Q4 axgn Deferred Tax Assets Right Of Use Liability
DeferredTaxAssetsRightOfUseLiability
837000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3140000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2335000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
520000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40954000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33934000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
28444000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
81000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
206000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43000
CY2019Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
7000
CY2018Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
15000
CY2017Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
6000
CY2019Q4 axgn Deferred Tax Assets Liabilities
DeferredTaxAssetsLiabilities
39932000
CY2018Q4 axgn Deferred Tax Assets Liabilities
DeferredTaxAssetsLiabilities
33876000
CY2017Q4 axgn Deferred Tax Assets Liabilities
DeferredTaxAssetsLiabilities
28357000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39932000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33876000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28357000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
-0.043
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.208
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.246
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6056000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5519000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-10754000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36250000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
22000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1910000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
41000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
17000
CY2019 us-gaap Lease Cost
LeaseCost
1994000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3133000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1719000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1565000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
87000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
17000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
30000
CY2019 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1773000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
16000
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0728
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2664000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
19000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4007000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
19000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2573000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
10000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2581000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2644000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
1000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
27251000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
41720000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
52000
CY2019Q4 axgn Lessee Operating Lease Liability Future Payments Amount
LesseeOperatingLeaseLiabilityFuturePaymentsAmount
38246000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
190000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3284000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
47000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1866000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
28000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2540000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
13000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3970000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
15000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2518000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
7000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2574000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
30111000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
43579000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
63000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
516000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
484000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
494000
CY2018Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
70000
CY2018Q3 us-gaap Area Of Land
AreaOfLand
8.6
CY2019Q1 axgn Threshold Period For Not Filing Response To Complaint
ThresholdPeriodForNotFilingResponseToComplaint
P30D
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q1 us-gaap Revenues
Revenues
23285000
CY2019Q2 us-gaap Revenues
Revenues
26701000
CY2019Q3 us-gaap Revenues
Revenues
28564000
CY2019Q4 us-gaap Revenues
Revenues
28162000
CY2019 us-gaap Revenues
Revenues
106712000
CY2019Q1 us-gaap Gross Profit
GrossProfit
19571000
CY2019Q2 us-gaap Gross Profit
GrossProfit
22457000
CY2019Q3 us-gaap Gross Profit
GrossProfit
24054000
CY2019Q4 us-gaap Gross Profit
GrossProfit
23281000
CY2019 us-gaap Gross Profit
GrossProfit
89363000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9504000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7022000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5571000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-7038000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-29135000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2018Q1 us-gaap Revenues
Revenues
17260000
CY2018Q2 us-gaap Revenues
Revenues
20584000
CY2018Q3 us-gaap Revenues
Revenues
22660000
CY2018Q4 us-gaap Revenues
Revenues
23433000
CY2018 us-gaap Revenues
Revenues
83937000
CY2018Q1 us-gaap Gross Profit
GrossProfit
14547000
CY2018Q2 us-gaap Gross Profit
GrossProfit
17478000
CY2018Q3 us-gaap Gross Profit
GrossProfit
19196000
CY2018Q4 us-gaap Gross Profit
GrossProfit
19793000
CY2018 us-gaap Gross Profit
GrossProfit
71014000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-5644000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-7427000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-4102000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-5224000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-22397000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60

Files In Submission

Name View Source Status
0001558370-20-001238-index-headers.html Edgar Link pending
0001558370-20-001238-index.html Edgar Link pending
0001558370-20-001238.txt Edgar Link pending
0001558370-20-001238-xbrl.zip Edgar Link pending
axgn-20191231.xsd Edgar Link pending
axgn-20191231x10k0cc357.htm Edgar Link pending
axgn-20191231x10k0cc357003.jpg Edgar Link pending
axgn-20191231x10k0cc357004.jpg Edgar Link pending
axgn-20191231x10k0cc357_htm.xml Edgar Link completed
axgn-20191231_cal.xml Edgar Link unprocessable
axgn-20191231_def.xml Edgar Link unprocessable
axgn-20191231_lab.xml Edgar Link unprocessable
axgn-20191231_pre.xml Edgar Link unprocessable
ex-10d51.htm Edgar Link pending
ex-21d1.htm Edgar Link pending
ex-23d1.htm Edgar Link pending
ex-23d2.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32d1.htm Edgar Link pending
ex-4d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending